Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Hyperthermia 1Colonic Neoplasms 1Cholangiocarcinoma 1Breast Neoplasms 1

Interventions

pembrolizumab 284Carboplatin 216Cisplatin 148Paclitaxel 145Gemcitabine 145Bevacizumab 117Pemetrexed 114Docetaxel 103Oxaliplatin 79Cyclophosphamide 79Dexamethasone 78durvalumab 77atezolizumab 77Fluorouracil 77Nivolumab 75130-nm albumin-bound paclitaxel 71Fulvestrant 68Capecitabine 64Injections 63Cetuximab 63Leucovorin 60Rituximab 56fludarabine 52Lenalidomide 49Prednisone 46venetoclax 43Irinotecan 43Letrozole 40enzalutamide 39tislelizumab 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Diathermy × 90 days × Clear all
NCT07224464 2026-05-15

The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.

New Phase Ltd.

Phase NA Recruiting
12 enrolled
BreastGastrointestinalGynecologicThoracic

Hyperthermia, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡